Development of megestrol acetate solid dispersion nanoparticles for enhanced oral delivery by using a supercritical antisolvent process

References

• YehSSWuSYLeeTPImprovement in quality-of-life measures and stimulation of weight gain after treatment with megestrol acetate oral suspension in geriatric cachexia: results of a double-blind, placebo-controlled studyJ Am Geriatr Soc200048548549210811540
   PubMed Web of Science ®Google Scholar
• TomískaMTomiskováMSalajkaFAdamZVorlícekJPalliative treatment of cancer anorexia with oral suspension of megestrol acetateNeoplasma200350322723312937858
   PubMed Web of Science ®Google Scholar
• DengZZhaoRDongLCWongGCharacterization of nanoparticles for drug delivery applicationsMicrosc Microanal200511Suppl 219341935
   Google Scholar
• SylvestreJPTangMCFurtosALeclairGMeunierMLerouxJCNanonization of megestrol acetate by laser fragmentation in aqueous milieuJ Control Release2011149327328021047539
   PubMed Web of Science ®Google Scholar
• ChoEChoWChaKHEnhanced dissolution of megestrol acetate microcrystals prepared by antisolvent precipitation process using hydrophilic additivesInt J Pharm20103961–2919820558265
   PubMed Web of Science ®Google Scholar
• JangKYoonSKimSENovel nanocrystal formulation of megestrol acetate has improved bioavailability compared with the conventional micronized formulation in the fasting stateDrug Des Devel Ther20148851858
   PubMed Web of Science ®Google Scholar
• HongSWLeeBSParkSJSolid dispersion formulations of megestrol acetate with copovidone for enhanced dissolution and oral bioavailabilityArch Pharm Res201134112713521468924
   PubMed Web of Science ®Google Scholar
• ShekunovBYChattopadhyayPSeitzingerJHuffRNanoparticles of poorly water-soluble drugs prepared by supercritical fluid extraction of emulsionsPharm Res200623119620416307386
   PubMed Web of Science ®Google Scholar
• ZhangZBShenZGWangJXZhaoHChenJFYunJNanonization of megestrol acetate by liquid precipitationInd Eng Chem Res2009481884938499
   Web of Science ®Google Scholar
• KimMSKimJSChoWSupersaturatable formulations for the enhanced oral absorption of sirolimusInt J Pharm20134451–210811623396259
   PubMedGoogle Scholar
• HaESBaekIHChoWHwangSJKimMSPreparation and evaluation of solid dispersion of atorvastatin calcium with Soluplus® by spray drying techniqueChem Pharm Bull (Tokyo)201462654555124881660
   PubMed Web of Science ®Google Scholar
• de la Torre-IglesiasPMGarcía-RodriguezJJTorradoGTorradoSTorrado-SantiagoSBolás-FernándezFEnhanced bioavailability and anthelmintic efficacy of mebendazole in redispersible microparticles with low-substituted hydroxypropylcelluloseDrug Des Devel Ther2014814671479
   Web of Science ®Google Scholar
• CoceroMJMartínAMatteaFVaronaSEncapsulation and co-precipitation processes with supercritical fluids: fundamentals and applicationsJ Supercrit Fluids2009473546555
   Web of Science ®Google Scholar
• AdeliEA comparative evaluation between utilizing SAS supercriti-cal fluid technique and solvent evaporation method in preparation of azithromycin solid dispersions for dissolution rate enhancementJ Supercrit Fluids201487921
   Web of Science ®Google Scholar
• KimMSBaekIHFabrication and evaluation of valsartan-polymer-surfactant composite nanoparticles by using the supercritical antisolvent processInt J Nanomedicine2014915167517625404856
   PubMedGoogle Scholar
• YinXDaintreeLSDingSItraconazole solid dispersion prepared by a supercritical fluid technique: preparation, in vitro characterization, and bioavailability in beagle dogsDrug Des Devel Ther2015928012810
   PubMed Web of Science ®Google Scholar
• KimMSInfluence of hydrophilic additives on the supersaturation and bioavailability of dutasteride-loaded hydroxypropyl-β-cyclodextrin nanostructuresInt J Nanomedicine2013812029203923737668
   PubMedGoogle Scholar
• HaESChooGHBaekIHKimMSFormulation, characterization, and in vivo evaluation of celecoxib-PVP solid dispersion nanopar-ticles using supercritical antisolvent processMolecules20141912203252033925486246
   PubMed Web of Science ®Google Scholar
• HaESChooGHBaekIHDissolution and bioavailability of lercanidipine-hydroxypropylmethyl cellulose nanoparticles with surfactantInt J Biol Macromol20157221822225159878
   PubMed Web of Science ®Google Scholar
• SeoJHParkJSJoMHRapid and sensitive LC-MS/MS method for determination of megestrol acetate in human plasma: application to a human pharmacokinetic studyBiomed Chromatogr201327440941522961730
   PubMed Web of Science ®Google Scholar
• LeeJYKangWSPiaoJYoonISKimDDChoHJSoluplus®/TPGS-based solid dispersions prepared by hot-melt extrusion equipped with twin-screw systems for enhancing oral bioavailability of valsartanDrug Des Devel Ther2015927452756
   PubMed Web of Science ®Google Scholar
• PalanisamyMKhanamJEffect of physiochemical variables on phase solubility and dissolution behavior of indomethacin solid dispersion systemJ Pharm Investig2014443147162
   Google Scholar
• KimMSKimJSParkHJChoWKChaKHHwangSJEnhanced bio-availability of sirolimus via preparation of solid dispersion nanoparticles using a supercritical antisolvent processInt J Nanomedicine201162997300922162657
   PubMed Web of Science ®Google Scholar
• KhanKARhodesCTEffect of compaction pressure on the dissolution efficiency of some direct compression systemsPharm Acta Helv197247105946074642457
   PubMedGoogle Scholar
• LerkPCSuckerHHEickeHFMicellization and solubilization behavior of sucrose laurate, a new pharmaceutical excipientPharm Dev Technol19961127369552328
   PubMedGoogle Scholar
• BerthelsenaRSjögrenbEJacobsenJCombining in vitro and in silico methods for better prediction of surfactant effects on the absorption of poorly water soluble drugs – a fenofibrate case exampleInt J Pharm20144731–235636524997410
   PubMedGoogle Scholar
• BaekIHKimJSHaESDissolution and oral absorption of pran-lukast nanosuspensions stabilized by hydroxypropylmethyl celluloseInt J Biol Macromol201467535724631786
   PubMed Web of Science ®Google Scholar
• LeeDHYeomDWSongYSImproved oral absorption of dutasteride via Soluplus®-based supersaturable self-emulsifying drug delivery system (S-SEDDS)Int J Pharm2014478134134725437113
   PubMedGoogle Scholar
• JunghannsJUMüllerRHNanocrystal technology, drug delivery and clinical applicationsInt J Nanomedicine20083329531018990939
   PubMed Web of Science ®Google Scholar